Theys, K., Abecasis, A., Libina, P., Gomes, P., Cabanas, J., Camacho, R. J., & Van Laethem, K. (2017). Discordant predictions of residual activity could impact dolutegravir prescription upon raltegravir failure.
Chicago Style (17th ed.) CitationTheys, Kristof, Ana Abecasis, Pieter Libina, Perpétua Gomes, Joaquim Cabanas, Ricardo J. Camacho, and Kristel Van Laethem. Discordant Predictions of Residual Activity Could Impact Dolutegravir Prescription upon Raltegravir Failure. 2017.
MLA (8th ed.) CitationTheys, Kristof, et al. Discordant Predictions of Residual Activity Could Impact Dolutegravir Prescription upon Raltegravir Failure. 2017.
Warning: These citations may not always be 100% accurate.